Opioids Archives - Rheumatology Advisor

Pain Management

CDC: 10.7% of US Adults Used Prescription Pain Medications From 2015 to 2018

June 30, 2020

In 2015 to 2018, 10.7% of US adults aged 20 years or older used one or more prescription pain medications.

Senior woman with joint pain in her hand

Rheumatoid Arthritis

Chronic Opioid Use May Be More Prevalent in Comorbid RA, Obesity

By

Kwamesha Joseph

June 12, 2020

Evidence suggests that the prevalence of chronic opioid use among patients with RA has increased over the last decade.

General Rheumatology

Antirheumatic Therapy Decreases Opioid Use in Patients With Early Inflammatory Arthritides

By

Morgan E. Meissner

April 28, 2020

Researchers assessed the effect of the opioid epidemic in Finnish patients with early inflammatory arthritides.

Gout

Evaluating the Treatment of Acute Gout Flares in the Emergency Department

By

Rheumatology Advisor Contributing Writer

March 26, 2020

Investigators addressed the treatment of acute gout flares in the emergency department.

Rheumatoid Arthritis

Mental Health History May Be Associated With Increased Chronic Opioid Therapy Risk in RA

By

Emily Pond

March 20, 2020

Researchers examined the association between mental health conditions and the risk for chronic opioid therapy in patients with rheumatoid arthritis.

Practice Management

Increase in Repeat Visits to the Emergency Department for Opioid-Related Emergencies

March 17, 2020

Emergency departments are increasingly seeing patients for repeat opioid-related care.

A bottle of hydrocodone, a needle, and a fine white powder.

Practice Management

Increase in Opioid-Related Unintentional Deaths and Suicides Since 2000

By

Brandon May

March 2, 2020

Between 2000 and 2017, unintentional deaths and suicides related to opioid use have increased substantially, whereas overall deaths from have decreased.

Practice Management

Treatment With Methadone and Buprenorphine May Lower Risk for Opioid Overdose Death

February 27, 2020

Medication treatment with methadone and buprenorphine is associated with a significantly lower risk for overdose death for people with opioid use disorder compared with nonmedication treatment.